State Street’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

State Street’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-179,411	Closed	-$2.27M	–	3757
2014 Q3	$2.27M	Buy	179,411 +1,517	+0.9%	+$22.7K	﹤0.01%	2957
2014 Q2	$3.03M	Buy	177,894 +1,322	+0.7%	+$19.7K	﹤0.01%	2862
2014 Q1	$2.38M	Sell	176,572 -2,405	-1%	-$31.5K	﹤0.01%	2983
2013 Q4	$2.29M	Buy	178,977 +36,844	+26%	+$386K	﹤0.01%	3003
2013 Q3	$1.29M	Buy	142,133 +7,106	+5%	+$58.9K	﹤0.01%	3200
2013 Q2	$971K	Buy	+135,027	New	+$991K	﹤0.01%	3189

State Street's DRTX Position: Q4 2014 in Review

State Street sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 179,411 shares — an estimated $2.27M sold.

State Street first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $3.03M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

State Street reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
State Street sold 179,411 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $2.27M.
State Street first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
State Street's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $3.03M in Q2 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on State Street's 13F filing for Q4 2014, filed 11 Feb 2015.